Safety of Antidiabetic Drugs Using in Children with Diabetes

YANG Yu,LIU Chao
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2009.05.007
2009-01-01
International Journal of Endocrinology and Metabolism
Abstract:The mobidity and morality of diabetes in childhood and adolescence increase dramatically along with the higher prevalence of diabetes worldwide. It is crucial to get tight glycemic control in order to reduce the risk of long-term chronic complications. Therefore, using antidiabetic drugs properly is very impor-tant. In adult patients,all kinds of antidiabetic drugs are commonly presctibed,but the safety of these drugs in children and adolescents is not fully understood. There were evidences of glibenclamide treating permanent neonatal diabetes,however,metformin is currently the only oral diabetes agent ratified to children patients. It can achieve similar glycemic control and weight loss safely as in adults. Other oral agents like snlfonylurea, repaglinide, nateglinide, α-glucosidase inhibitors and TZDs are not qualified for children's prescription. Insu-lin analogues including lispro, aspart and detemir are as safe and efficacious as human insulin, and even more acceptable and flexible in usage. Glargine is not recommended because of its carcinogenic possibility in chil-dren,
What problem does this paper attempt to address?